Marshall Wace
CLOV icon

Marshall Wace’s Clover Health Investments CLOV Stock Holding History

Marshall Wace’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,523,047
Closed -$9.83M – 2957
2025
Q2 		$9.83M Sell
3,523,047
-1,052,480
-23% -$3.46M 0.01% 845
2025
Q1 		$16.4M Buy
4,575,527
+805,762
+21% +$3.24M 0.02% 573
2024
Q4 		$11.9M Buy
3,769,765
+2,360,902
+168% +$8.44M 0.01% 733
2024
Q3 		$3.97M Buy
1,408,863
+1,364,007
+3,041% +$3.12M 0.01% 1089
2024
Q2 		$55.2K Buy
+44,856
New +$40.3K ﹤0.01% 2441
2022
Q1 		– Sell
-1,245,630
Closed -$4.63M – 3439
2021
Q4 		$4.63M Buy
+1,245,630
New +$7.64M 0.01% 1414

Other funds holding CLOV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.14B AUM 134.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return